• 1
    Petersen RC. Mild cognitive impairment as a diagnostic entity. J Intern Med 2004; 256: 18394.
  • 2
    Ritchie K, Artero S, Touchon J. Classification criteria for mild cognitive impairment: a population-based validation study. Neurology 2001; 56: 3742.
  • 3
    Petersen RC, Doody R, Kurz A et al. Current concepts in mild cognitive impairment. Arch Neurol 2001; 58: 198592.
  • 4
    DeCarli C, Frisoni GB, Clark CM et al. Qualitative estimates of medial temporal atrophy as a predictor of progression from mild cognitive impairment to dementia. Arch Neurol 2007; 64: 10815.
  • 5
    Duara R, Loewenstein DA, Potter E et al. Medial temporal lobe atrophy on MRI scans and the diagnosis of Alzheimer disease. Neurology 2008; 71: 198692.
  • 6
    Dickerson BC, Goncharova I, Sullivan MP et al. MRI-derived entorhinal and hippocampal atrophy in incipient and very mild Alzheimer's disease. Neurobiol Aging 2001; 22: 74754.
  • 7
    Du AT, Schuff N, Amend D et al. Magnetic resonance imaging of the entorhinal cortex and hippocampus in mild cognitive impairment and Alzheimer's disease. J Neurol Neurosurg Psychiatry 2001; 71: 4417.
  • 8
    Chetelat G, Landeau B, Eustache F et al. Using voxel-based morphometry to map the structural changes associated with rapid conversion in MCI: a longitudinal MRI study. Neuroimage 2005; 27: 93446.
  • 9
    Wahlund LO, Julin P, Johansson SE, Scheltens P. Visual rating and volumetry of the medial temporal lobe on magnetic resonance imaging in dementia: a comparative study. J Neurol Neurosurg Psychiatry 2000; 69: 6305.
  • 10
    Jack CR, Petersen RC, Xu Y et al. Rates of hippocampal atrophy correlate with change in clinical status in aging and AD. Neurology 2000; 55: 4849.
  • 11
    Killiany RJ, Hyman BT, Gomez-Isla T et al. MRI measures of entorhinal cortex vs hippocampus in preclinical AD. Neurology 2002; 58: 118896.
  • 12
    Devanand DP, Pradhaban G, Liu X et al. Hippocampal and entorhinal atrophy in mild cognitive impairment: prediction of Alzheimer disease. Neurology 2007; 68: 82836.
  • 13
    Risacher SL, Saykin AJ, West JD, Shen L, Firpi HA, McDonald BC. Alzheimer's Disease Neuroimaging Initiative. Baseline MRI predictors of conversion from MCI to probable AD in the ADNI cohort. Curr Alzheimer Res 2009; 6: 34761.
  • 14
    Scheltens P, Leys D, Barkhof F et al. Atrophy of medial temporal lobes on MRI in “probable” Alzheimer's disease and normal ageing: diagnostic value and neuropsychological correlates. J Neurol Neurosurg Psychiatry 1992; 55: 96772.
  • 15
    Visser PJ, Verhey FR, Hofman PA, Scheltens P, Jolles J. Medial temporal lobe atrophy predicts Alzheimer's disease in patients with minor cognitive impairment. J Neurol Neurosurg Psychiatry 2002; 72: 4917.
  • 16
    Korf ES, Wahlund LO, Visser PJ, Scheltens P. Medial temporal lobe atrophy on MRI predicts dementia in patients with mild cognitive impairment. Neurology 2004; 63: 94100.
  • 17
    Bouwman FH, Schoonenboom SN, van der Flier WM et al. CSF biomarkers and medial temporal lobe atrophy predict dementia in mild cognitive impairment. Neurobiol Aging 2007; 28: 10704.
  • 18
    Burton EJ, Barber R, Mukaetova-Ladinska EB et al. Medial temporal lobe atrophy on MRI differentiates Alzheimer's disease from dementia with Lewy bodies and vascular cognitive impairment: a prospective study with pathological verification of diagnosis. Brain 2009; 132: 195203.
  • 19
    van de Pol LA, Korf ES, van der Flier WM et al. Magnetic resonance imaging predictors of cognition in mild cognitive impairment. Arch Neurol 2007; 64: 10238.
  • 20
    Launer LJ, Scheltens P, Lindeboom J, Barkhof F, Weinstein HC, Jonker C. Medial temporal lobe atrophy in an open population of very old persons: cognitive, brain atrophy, and sociomedical correlates. Neurology 1995; 45: 74752.
  • 21
    Galton CJ, Patterson K, Graham K et al. Differing patterns of temporal atrophy in Alzheimer's disease and semantic dementia. Neurology 2001; 57: 21625.
  • 22
    Barber R, Ballard C, McKeith IG, Gholkar A, O'Brien JT. MRI volumetric study of dementia with Lewy bodies: a comparison with AD and vascular dementia. Neurology 2000; 54: 13049.
  • 23
    Tam CWC, Burton EJ, McKeith IG, Burn DJ, O'Brien JT. Temporal lobe atrophy on MRI in Parkinson's disease with dementia: a comparison with Alzheimer's disease and dementia with Lewy bodies. Neurology 2005; 64: 8615.
  • 24
    Galton CJ, Patterson K, Xuereb JH, Hodges JR. Atypical and typical presentations of Alzheimer's disease: a clinical, neuropsychological, neuroimaging and pathological study of 13 cases. Brain 2000; 3: 48498.
  • 25
    Kemp PM, Holmes C, Hoffmann SM et al. Alzheimer's disease: differences in technetium-99 m HMPAO SPECT scan findings between early onset and late onset dementia. J Neurol Neurosurg Psychiatry 2003; 74: 7159.
  • 26
    Jones BF, Barnes J, Uylings HB et al. Differential regional atrophy of the cingulate gyrus in Alzheimer disease: a volumetric MRI study. Cereb Cortex 2006; 16: 17018.
  • 27
    Karas G, Scheltens P, Rombouts S et al. Precuneus atrophy in early-onset Alzheimer's disease: a morphometric structural MRI study. Neuroradiology 2007; 49: 96776.
  • 28
    Whitwell JL, Dickson DW, Murray ME et al. Neuroimaging correlates of pathologically defined subtypes of Alzheimer's disease: a case-control study. Lancet Neurol 2012; 11: 86877.
  • 29
    Cherbuin N, Leach LS, Christensen H, Anstey KJ. Neuroimaging and ApoE genotype: a systematic qualitative review. Dement Geriatr Cogn Disord 2007; 24: 34862.
  • 30
    Liu CC, Kanekiyo T, Xu H, Bu G. Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy. Nat Rev Neurol 2013; 9: 10618.
  • 31
    Jack CR, Petersen RC, Xu YC et al. Medial temporal atrophy on MRI in normal aging and very mild Alzheimer's disease. Neurology 1997; 49: 78694.
  • 32
    van de Pol LA, Hensel A, van der Flier WM et al. Hippocampal atrophy on MRI in frontotemporal lobar degeneration and Alzheimer's disease. J Neurol Neurosurg Psychiatry 2006; 77: 43942.
  • 33
    Barkhof F, Polvikoski TM, van Straaten EC et al. The significance of medial temporal lobe atrophy: a postmortem MRI study in the very old. Neurology 2007; 69: 15217.
  • 34
    Schoonenboom NS, van der Flier WM, Blankenstein MA et al. CSF and MRI markers independently contribute to the diagnosis of Alzheimer's disease. Neurobiol Aging 2008; 29: 66975.
  • 35
    van Rossum IA, Visser PJ, Knol DL et al. Injury markers but not amyloid markers are associated with rapid progression from mild cognitive impairment to dementia in Alzheimer's disease. J Alzheimers Dis 2012; 29: 31927.
  • 36
    Westman E, Simmons A, Muehlboeck JS et al. AddNeuroMed and ADNI: similar patterns of Alzheimer's atrophy and automated MRI classification accuracy in Europe and North America. Neuroimage 2011; 58: 81828.
  • 37
    Lehman M, Koedam EL, Barnes J et al. Visual ratings of atrophy in MCI: prediction of conversión and relationship with CSF biomarkers. Neurobiol Aging 2013; 34: 7382.
  • 38
    Lovestone S, Francis P, Strandgaard K. Biomarkers for disease modification trials–the innovative medicines initiative and AddNeuroMed. J Nutr Health Aging 2007; 11: 35961.
  • 39
    Lovestone S, Francis P, Kloszewska I et al. AddNeuroMed – the European collaboration for the discovery of novel biomarkers for Alzheimer's disease. Ann N Y Acad Sci 2009; 1180: 3646.
  • 40
    McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS Alzheimer's disease RDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 1984; 34: 93944.
  • 41
    Folstein MF, Folstein SE, McHugh PR. “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12: 18998.
  • 42
    Rosen WG, Mohs RC, Davis KL. A new rating scale for Alzheimer's disease. Am J Psychiatry 1984; 141: 135664.
  • 43
    Shaw LM, Vanderstichele H, Knapik-Czajka M et al. Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects. Ann Neurol 2009; 65: 40313.
  • 44
    Hixson JE, Vernier DT. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J Lipid Res 1990; 31: 5458.
  • 45
    Jack CR, Bernstein MA, Fox NC et al. The Alzheimer's disease neuroimaging initiative (ADNI): MRI methods. J Magn Reson Imaging 2008; 27: 68591.
  • 46
    Simmons A, Westman E, Muehlboeck S et al. MRI measures of Alzheimer's disease and the AddNeuroMed study. Ann N Y Acad Sci 2009; 1180: 4755.
  • 47
    Simmons A, Westman E, Muehlboeck S et al. The AddNeuroMed framework for multi-centre MRI assessment of Alzheimer's disease: experience from the first 24 months. Int J Geriatr Psychiatry 2011; 26: 7582.
  • 48
    Cavallin L, Bronge L, Zhang Y et al. Comparison between visual assessment of MTA and hippocampal volume in an elderly, non-demented population. Acta Radiol 2012; 53: 5739.
  • 49
    Hawass NE. Comparing the sensitivities and specificities of two diagnostic procedures performed on the same group of patients. Br J Radiol 1997; 70: 3606.
  • 50
    Jonker C, Geerlings MI, Schmand B. Are memory complaints predictive for dementia? A review of clinical and population-based studies. Int J Geriatr Psychiatry 2000; 15: 98391.
  • 51
    Braak H, Braak E. Alzheimer's disease affects limbic nuclei of the thalamus. Acta Neuropathol 1991; 81: 2618.
  • 52
    Dubois B, Feldman HH, Jacova C et al. Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria. Lancet Neurol 2007; 6: 73446.
  • 53
    Albert MS, DeKosky ST, Dickson D et al. The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 2011; 7: 2709.
  • 54
    Spulber G, Simmons A, Muehlboeck JS et al. An MRI-based index to measure the severity of Alzheimer's disease-like structural pattern in subjects with mild cognitive impairment. J Intern Med 2013; 273: 396409.
  • 55
    Raz N, Gunning-Dixon F, Head D, Rodrigue KM, Williamson A, Acker JD. Aging, sexual dimorphism, and hemispheric asymmetry of the cerebral cortex: replicability of regional differences in volume. Neurobiol Aging 2004; 25: 37796.
  • 56
    Salat DH, Buckner RL, Snyder AZ et al. Thinning of the cerebral cortex in aging. Cereb Cortex 2004; 14: 72130.
  • 57
    Walhovd KB, Fjell AM, Reinvang I et al. Effects of age on volumes of cortex, white matter and subcortical structures. Neurobiol Aging 2005; 26: 126170.
  • 58
    Fjell AM, Walhovd KB, Fennema-Notestine C et al. One-year brain atrophy evident in healthy aging. J Neurosci 2009; 29: 1522331.
  • 59
    Xu J, Kobayashi S, Yamaguchi S, Iijima K, Okada K, Yamashita K. Gender effects on age-related changes in brain structure. AJNR Am J Neuroradiol 2000; 21: 1128.
  • 60
    Sowell ER, Peterson BS, Kan E et al. Sex differences in cortical thickness mapped in 176 healthy individuals between 7 and 87 years of age. Cereb Cortex 2007; 17: 155060.
  • 61
    Pfefferbaum A, Rohlfing T, Rosenbloom MJ, Chu W, Colrain IM, Sullivan EV. Variation in longitudinal trajectories of regional brain volumes of healthy men and women (ages 10 to 85 years) measured with atlas-based parcellation of MRI. Neuroimage 2013; 65: 17693.
  • 62
    Raber J, Huang Y, Ashford JW. ApoE genotype accounts for the vast majority of AD risk and AD pathology. Neurobiol Aging 2004; 25: 64150.
  • 63
    Rogalski EJ, Rademaker A, Harrison TM et al. ApoE E4 is a susceptibility factor in amnestic but not aphasic dementias. Alzheimer Dis Assoc Disord 2011; 25: 15963.
  • 64
    van der Flier WM, Pijnenburg YA, Fox NC, Scheltens P. Early-onset versus late-onset Alzheimer's disease: the case of the missing ApoE varepsilon4 allele. Lancet Neurol 2011; 10: 2808.
  • 65
    Lehmann M, Koedam EL, Barnes J et al. Posterior cerebral atrophy in the absence of medial temporal lobe atrophy in pathologically-confirmed Alzheimer's disease. Neurobiol Aging 2012; 33: 627.e1e12.
  • 66
    Pasquier F, Leys D, Weerts JG, Mounier-Vehier F, Barkhof F, Scheltens P. Inter- and intraobserver reproducibility of cerebral atrophy assessment on MRI scans with hemispheric infarcts. Eur Neurol 1996; 36: 26872.
  • 67
    Fazekas F, Chawluk JB, Alavi A, Hurtig HI, Zimmerman RA. MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging. Am J Roentgenol 1987; 149: 3516.